Know about the revolutionary therapies, personalised medicine and cancer treatments that are changing the game!

EMA committee recommends extension of marketing authorisation for Janssen-Cilag’s subcutaneous Rybrevant to treat advanced EGFR-mutated NSCLC: Beerse, Belgium Tuesday, February ...

The committee recommended the new formulation in two EGFR-mutated advanced NSCLC settings, for which intravenous Rybrevant is already available.

EU regulators have issued a positive opinion for the extension of the market authorization for subcutaneous formulation of ...

Halozyme (HALO) announced that Janssen-Cilag International, a Johnson & Johnson (JNJ) company, received a positive opinion from the ...

The Committee for Medicinal Products for Human Use (CHMP) has recommended that the subcutaneous (SC) formulation be approved ...

Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended an ...

Honey is a sugar substitute that may also have many health benefits. Read about the different kinds of honey you can try, its benefits and its side effects. Suchandrima Bhowmik is a freelance ...

Thus, the high mutation rate of C29095U could be more accurately estimated ... However, a binary model of basepairing alone is sufficient to capture much of the variation in synonymous substitution ...

There are several types of thyroid cancer, each originating in a different type of thyroid cell. The overgrowth occurs due to hereditary or acquired mutations (genetic changes). Risk factors ...

MANILA, Philippines — Sen. Risa Hontiveros filed a substitute bill for the "Prevention of Adolescent Pregnancy Act" following the withdrawal of signatures by several senators and concerns raised ...

exon 19 deletions or exon 21 substitution mutations. The NICE decision was supported by data from the Phase III ADAURA trial (NCT05120349), which demonstrated that post-surgical treatment with ...